Target intelligence / Profile preview

White spot syndrome virus genes (WSSV genes)

Target
WSSV genes
Molecular classification
Viral genome, Viral structural protein, Viral non-structural protein, Viral enzyme
01

Overview

White spot syndrome virus (WSSV) genes constitute the large, double-stranded DNA genome of the sole member of the genus Whispovirus within the family Nimaviridae (ICTV, 2023). These genes are responsible for the extreme virulence and rapid replication of the virus, which causes White Spot Syndrome (WSS), a devastating disease in penaeid shrimp and other crustaceans that can lead to 100% mortality within days (NCBI, 2024). The genome encodes approximately 180 open reading frames, with primary therapeutic targets including structural proteins like VP28 and VP19, which are essential for viral attachment and entry into host cells (Yi et al., 2004; PubMed). Other critical targets include non-structural genes involved in DNA synthesis, such as DNA polymerase and ribonucleotide reductase (Van Hulten et al., 2001). Current experimental strategies focus on silencing these genes using RNA interference (RNAi) or inducing protective immunity through DNA and recombinant protein vaccines (Robalino et al., 2005; Rout et al., 2007). While no commercial drugs are currently approved for human use, these genetic sequences are the central focus of biosecurity and antiviral research in the global aquaculture industry.

Other names
White spot syndrome virus genomeWSSV open reading framesWhite spot baculiform virus genesNimaviridae genes
02

Mechanism of action

Inhibition of viral replication through RNA interference (RNAi) mediated gene silencing, blocking of viral entry by neutralizing structural proteins with antibodies or competitive inhibitors, and induction of host innate antiviral immunity through vaccination.

03

Biological functions

Viral replicationViral entryHost cell attachmentViral assemblyHost-pathogen interactionPathogenesis
04

Disease associations

InfectionWhite spot syndrome
05

Safety considerations

Environmental stability and leakage of nucleic acid-based treatmentsPotential for viral mutation leading to escape mutantsOff-target effects in non-target aquatic speciesLack of standardized delivery systems for large-scale aquaculture
06

Interacting drugs

dsRNA targeting VP28

5 more in the full profile.

07

Biomarkers

WSSV DNA copy number (qPCR)VP28 mRNA expression levelsTotal hemocyte count (THC)Phenoloxidase activity

Beyond the preview

Go deeper on White spot syndrome virus genes (WSSV genes).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on White spot syndrome virus genes (WSSV genes).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call